Efficacy of CHX Cloths Versus CHX Soaps for Bathes Before Orthopedic Surgery (POL)
Skin Preparation of Patients Before Orthopedic Surgery : A Randomized Controlled Study on the Efficacy of Chlorhexidine Cloths Versus Chlorhexidine Soaps
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: Caroline Landelle, PharmD, PhD
- Phone Number: 0033476765643
- Email: CLandelle@chu-grenoble.fr
Study Contact Backup
- Name: Brice Rubens Duval, MD
- Phone Number: 0033476768796
- Email: BRubensduval@chu-grenoble.fr
Study Locations
-
-
-
Grenoble, France, 38700
- CHU de Grenoble Alpes
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- adult patients,
- undergoing orthopedic surgery: programmed hip prosthesis (non-urgent),
- admitted the day before the operation
- and having given their written consent.
Exclusion Criteria:
- presence of a documented infection at the time of the intervention,
- presence of skin wounds,
- presence of antibiotic treatment within 15 days before the operation
- intolerance to CHX,
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Interventional
Skin preparations (the day before and the morning of the operation) with the 2% CHX cloths
|
skin preparation in 2% CHX cloths
|
|
No Intervention: Control
Skin preparations (the day before and the morning of the operation) with the 4% CHX soap (standard of care)
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Relative decrease in the number of bacterial colonies before the antiseptic preparation of the operating site at the surgical room (T1)
Time Frame: Between the patient's admission to the CHU GA and just before the antiseptic preparation of the operating site at the surgical room (Day 1)
|
Relative decrease in the number of bacterial colonies measured between the patient's admission to the Grenoble Alps University Hospital (CHU GA) (T0) and after 2 preoperative skin preparations (the day before and the morning of the operation), and just before the antiseptic preparation of the operating site at the surgical room (T1) in the 2% CHX cloths group versus the 4% CHX soap group.
|
Between the patient's admission to the CHU GA and just before the antiseptic preparation of the operating site at the surgical room (Day 1)
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Relative decrease in the number of bacterial colonies after 1 preoperative skin preparation
Time Frame: Between the patient's admission to the CHU GA and after 1 preoperative skin preparation (Day 0)
|
Relative decrease in the number of bacterial colonies measured between the patient's admission to the CHU GA (T0) and after 1 preoperative skin preparation (the day before the evening of the operation)
|
Between the patient's admission to the CHU GA and after 1 preoperative skin preparation (Day 0)
|
|
Relative decrease in the number of bacterial colonies after 2 preoperative skin preparations
Time Frame: Between the patient's admission to the CHU GA and after 2 preoperative skin preparations (Day 1)
|
Relative decrease in the number of bacterial colonies measured between the patient's admission to the CHU GA (T0) and after 2 preoperative skin preparations (the night before and the morning of the operation)
|
Between the patient's admission to the CHU GA and after 2 preoperative skin preparations (Day 1)
|
|
Significant predictors of a decrease in bacterial colonization
Time Frame: Between the patient's admission to the CHU GA and just before the antiseptic preparation of the operating site at the surgical room (Day 1)
|
Significant predictors of a decrease in bacterial colonization among the sex, age of the patients, their co-morbidities, the use of cloths and the time between the last preoperative skin preparation and the skin sample in the operating room
|
Between the patient's admission to the CHU GA and just before the antiseptic preparation of the operating site at the surgical room (Day 1)
|
|
Percentage of skin adverse reactions
Time Frame: Between the patient's admission to the CHU GA and just before the antiseptic preparation of the operating site at the surgical room (Day 1)
|
Percentage of skin adverse reactions after 2 preoperative skin preparations in the 2% CHX cloths group versus the 4% CHX soap group.
|
Between the patient's admission to the CHU GA and just before the antiseptic preparation of the operating site at the surgical room (Day 1)
|
|
Nursing load
Time Frame: Between the patient's admission to the CHU GA and just before the antiseptic preparation of the operating site at the surgical room (Day 1)
|
Nursing load in the 2% CHX cloths group versus 4% CHX soap group according to the Soins Infirmiers Individualisés à la Personne Soignée (SIIPS) scale
|
Between the patient's admission to the CHU GA and just before the antiseptic preparation of the operating site at the surgical room (Day 1)
|
|
Duration of preoperative skin preparation
Time Frame: Between the patient's admission to the CHU GA and just before the antiseptic preparation of the operating site at the surgical room (Day 1)
|
Duration of preoperative skin preparation in minutes in the 2% CHX cloths group versus 4% CHX soap group.
|
Between the patient's admission to the CHU GA and just before the antiseptic preparation of the operating site at the surgical room (Day 1)
|
|
Responses to a questionnaire for patients and adherence score
Time Frame: Between surgery and discharge from the hospital (Day 4)
|
Responses to a questionnaire for patients and adherence score in the 2% CHX cloths group versus the 4% CHX soap group.
|
Between surgery and discharge from the hospital (Day 4)
|
|
Responses to a semi-structured interview intended for healthcare professionals
Time Frame: Interview at the end of the inclusion of patients (through study completion, an average of 6 months)
|
Responses to a semi-structured interview intended for healthcare professionals who cared for patients randomized to the 2% CHX cloths group versus the 4% CHX soap group.
|
Interview at the end of the inclusion of patients (through study completion, an average of 6 months)
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Estimated)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
Other Study ID Numbers
- 38RC19.254
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.